Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening [NA]
An exploratory study evaluating the relevance of a blood test in the management of patients in the context of colorectal cancer screening; t…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial evaluating Xeloda (capecitabine) or tegafur-uracil with folinic acid in advanced or metastatic colorectal cancer has completed…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Adjuvant Low Dose Aspirin in Colorectal Cancer [Phase 3]
Phase 3 trial results for adjuvant low-dose aspirin in colorectal cancer have been posted.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating temozolomide, cisplatin, and nivolumab in colorectal cancer (colorectal adenocarcinoma) and currently not …
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy [EARLY_Phase 1]
A Phase 1 trial examining combined omeprazole and low-dose aspirin to identify colorectal cancer biomarkers for preventive efficacy has been…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions
WAYCEN Inc. is evaluating WAYMED Endo CL CS for automated detection and diagnosis of colorectal lesions, including adenomas and sessile serr…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers [Phase 1]
This Phase 1 clinical trial update describes S095029 as monotherapy and in combination with Sym021 in patients with advanced solid tumors, f…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer
Completion update for a clinical trial evaluating exosome-based detection of molecular residual disease in stage II-III colorectal cancer.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease [Phase 2]
Phase 2 trial evaluating high-dose melphalan delivered directly into the liver, followed by an approved cancer treatment, versus approved ca…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy
A clinical trial exploring the optimal surveillance strategy after a positive FIT and a negative colonoscopy in colorectal cancer screening.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting
This document provides an update on a real-world cohort study evaluating regorafenib in patients with metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response [NA]
A terminated clinical trial (NCT02439008) investigating early biomarkers of tumor response to high-dose hypofractionated radiotherapy across…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. [Phase 1]
Phase 1 clinical trial evaluating PF-07985045 alone or with other anti-cancer therapies in adults with advanced solid tumors bearing gene al…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease [Phase 2]
AbbVie is conducting a Phase 2 study to assess adverse events and changes in disease activity in adults with post-adjuvant ctDNA-positive co…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
This clinical trial investigates how biological, genetic, and constitutional factors, plus non-invasive monitoring, can help assess individu…
-
CLINICAL_TRIALS other · 2026-03-13Clinical Trial Update: Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners [Phase 2]
A Phase 2 clinical trial update notes termination of a study evaluating a neuroscience-based technique in colorectal cancer, bladder cancer,…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating TAS-102 (trifluridine/tipiracil) in combination with radiation therapy for liver metastases from colorectal can…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN) [Phase 2]
Phase 2 clinical trial evaluating pre-operative targeted therapies for patients with molecularly selected resectable colorectal cancer; recr…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) [Phase 1, Phase 2]
PMV Pharmaceuticals is evaluating PC14586 in a Phase 1/2 trial for advanced solid tumors harboring the TP53 Y220C mutation. The study is cur…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort
A completed population-cohort study assessing recurrence of colorectal cancer after five years of follow-up.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI [Phase 1]
Phase 1 clinical trial update evaluating a Technetium-99m labeled HYNIC-FAPI imaging agent to visualize fibroblast activation protein expres…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors [Phase 1]
A Phase 1 study evaluating Zanzalintinib in combination with immuno-oncology agents in patients with various solid tumors; recruitment is on…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) [Phase 1]
Phase 1 clinical trial MK-7119-002 assesses safety and pharmacokinetics of tucatinib (MK-7119) in Chinese participants with cancer; the stud…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy [Phase 1]
Open-label Phase 1b trial evaluating ulixertinib with cetuximab, or ulixertinib with cetuximab and encorafenib, for unresectable or metastat…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
This clinical trial update outlines a Memorial Sloan Kettering study evaluating cellular changes in colon/colorectal cancer after radioembol…